Bristol Advisors’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$157K Hold
19,128
0.37% 20
2018
Q4
$106K Buy
+19,128
New +$106K 0.13% 48